Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 4
2017 1
2020 3
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer.
D'Andrea D, Foerster B, Matin SF, Ku JH, Muilwijk T, Monteiro LL, Liao R, Petros FG, Spiess PE, Bivalacqua TJ, Hendricksen K, van Rhijn BWG, Shabsigh A, Briganti A, Joniau S, Kassouf W, Pierorazio PM, Margulis V, Necchi A, Shariat SF; UTUC collaboration. D'Andrea D, et al. Eur Urol Open Sci. 2020 Jun 14;19:16-19. doi: 10.1016/j.euros.2020.04.001. eCollection 2020 Jul. Eur Urol Open Sci. 2020. PMID: 34337449 Free PMC article. No abstract available.
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
Pradere B, D'Andrea D, Schuettfort VM, Foerster B, Quhal F, Mori K, Abufaraj M, Margulis V, Deuker M, Briganti A, Muilwijk T, Hendricksen K, Lotan Y, Karakiewic P, F Shariat S; UTUC collaboration. Pradere B, et al. World J Urol. 2021 Jul;39(7):2567-2577. doi: 10.1007/s00345-020-03479-3. Epub 2020 Oct 16. World J Urol. 2021. PMID: 33067726 Free PMC article.
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Foerster B, Abufaraj M, Petros F, Azizi M, Gupta M, Schweitzer D, Margulis V, Iwata T, Kimura S, Shabsigh A, Briganti A, Ku JH, Muilwijk T, Kassouf W, Matin SF, Spiess PE, Pierorazio PM, Hendricksen K, Shariat SF; UTUC Collaboration. Foerster B, et al. J Urol. 2020 Jun;203(6):1101-1108. doi: 10.1097/JU.0000000000000737. Epub 2020 Jan 2. J Urol. 2020. PMID: 31898919
Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
Foerster B, Moschini M, Abufaraj M, Soria F, Gust KM, Rouprêt M, Karakiewicz PI, Briganti A, Rink M, Kluth L, Mathieu R, Margulis V, Lotan Y, Aziz A, John H, Shariat SF; UTUC Collaboration. Foerster B, et al. Clin Genitourin Cancer. 2017 Dec;15(6):e1039-e1045. doi: 10.1016/j.clgc.2017.06.003. Epub 2017 Jun 19. Clin Genitourin Cancer. 2017. PMID: 28694147
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M, Xylinas E, Kluth L, Trinh QD, Lee RK, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Kautzky-Willer A, Bachmann A, Shariat SF; UTUC Collaboration. Rieken M, et al. Eur J Surg Oncol. 2014 Jan;40(1):113-20. doi: 10.1016/j.ejso.2013.09.016. Epub 2013 Sep 20. Eur J Surg Oncol. 2014. PMID: 24113620
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E, Novara G, Raman JD, Lotan Y, Weizer A, Roupret M, Pycha A, Scherr DS, Seitz C, Ficarra V, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Shariat SF; UTUC Collaboration. Xylinas E, et al. BJU Int. 2013 Aug;112(4):453-61. doi: 10.1111/j.1464-410X.2012.11649.x. Epub 2013 Mar 6. BJU Int. 2013. PMID: 23464979 Free article.
Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M, Schubert T, Xylinas E, Kluth L, Rouprêt M, Trinh QD, Lee RK, Al Hussein Al Awamlh B, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF; UTUC Collaboration. Rieken M, et al. Eur J Surg Oncol. 2014 Dec;40(12):1693-9. doi: 10.1016/j.ejso.2014.03.018. Epub 2014 Apr 13. Eur J Surg Oncol. 2014. PMID: 24780094
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS, Shariat SF; UTUC Collaboration. Xylinas E, et al. Eur Urol. 2014 Mar;65(3):650-8. doi: 10.1016/j.eururo.2013.09.003. Epub 2013 Sep 19. Eur Urol. 2014. PMID: 24070577
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
Xylinas E, Rink M, Margulis V, Faison T, Comploj E, Novara G, Raman JD, Lotan Y, Guillonneau B, Weizer A, Pycha A, Scherr DS, Seitz C, Sun M, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Gönen M, Shariat SF; UTUC Collaboration. Xylinas E, et al. J Urol. 2013 Feb;189(2):468-73. doi: 10.1016/j.juro.2012.09.036. Epub 2012 Dec 14. J Urol. 2013. PMID: 23253960
Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
Xylinas E, Kluth LA, Rieken M, Lee RK, Elghouayel M, Ficarra V, Margulis V, Lotan Y, Rouprêt M, Martinez-Salamanca JI, Matsumoto K, Seitz C, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF; UTUC Collaboration. Xylinas E, et al. BJU Int. 2014 Jul;114(1):56-61. doi: 10.1111/bju.12400. BJU Int. 2014. PMID: 24053463